Parts

Table

Here is an overview of all the new parts that were used in our project. Altogether, more parts were designed for this project but not characterised well enough to contribute to the parts. Nevertheless, these constructs helped us to get an idea of how our sensing system works.

Nitric oxide sensing parts:

For the success of our project, we needed to build a nitric oxide sensor which could recognise lower nitric oxide concentrations and elicit a higher response to induction than previously described parts.

Name Type Description Designers Length in bp Picture for composite parts
BBa_K4387000 Promoter pNorVβ, nitric oxide inducible Jana Mehdy 256
BBa_K4387001 codon-optimized NorR coding for transcription factor NorR Jana Mehdy, Caua Westmann 1515
BBa_K4387003 piGEM1 (negative control) coding for sfGFP and NorR, does not contain any promoter Jana Mehdy, Lea Brüllmann, Marine Mausy 2410
BBa_K4387004 piGEM3 coding for sfGFP and NorR under the control of inducible ETH promoter pNorV Jana Mehdy, Lea Brüllmann, Marine Mausy 2713
BBa_K4387005 piGEM2_1RBS coding for sfGFP and NorR under the control of inducible pNorVβ. This construct contains 1 RBS in front of sfGFP Jana Mehdy, Lea Brüllmann, Marine Mausy 2674
BBa_K4387006 piGEM2_2RBS coding for sfGFP and NorR under the control of inducible pNorVβ. This construct contains 2 RBSs in front of sfGFP Jana Mehdy, Lea Brüllmann, Marine Mausy 2697
BBa_K4387007 piGEM2_3RBS coding for sfGFP and NorR under the control of inducible pNorVβ. This construct contains 3 RBSs in front of sfGFP Jana Mehdy, Lea Brüllmann, Marine Mausy 2717
BBa_K4387009 piGEM2_2RBS without a positive feed-back loop coding for sfGFP under the control of inducible pNorVβ. This construct contains 2 RBSs in front of sfGFP Jana Mehdy, Lea Brüllmann, Marine Mausy 1156
BBa_K4387020 RBS strong RBS Jana Mehdy, Marine Mausy 12

Nanobody constructs:

To dampen inflammation, we needed a construct that could interfer in the pro-inflammatory signaling. To fulfill this mission, we decided to use a nanobody against the cytokine TNFα. First, several nanobody candidates were tested and characterized to find the best suitable construct.

Name Type Description Designers Length in bp Picture for composite parts
BBa_K4387996 VHH#2B Monovalent Anti-Tumour Necrosis Factor Nanobody (VHH#2B) Nathalie Weibel 369
BBa_K4387995 VHH#3E Monovalent Anti-Tumour Necrosis Factor Nanobody (VHH#3E) Nathalie Weibel 387
BBa_K4387994 VHH#12B Monovalent Anti-Tumour Necrosis Factor Nanobody (VHH#12B) Nathalie Weibel 369
BBa_K4387993 Biv. VHH#2B Bivalent Anti-Tumour Necrosis Factor Nanobody (biv. VHH#2B) Nathalie Weibel 774
BBa_K4387992 Biv. VHH#3E Bivalent Anti-Tumour Necrosis Factor Nanobody (biv. VHH#3E) Nathalie Weibel 810
BBa_K4387991 Biv. VHH#12B Bivalent Anti-Tumour Necrosis Factor Nanobody (biv. VHH#12B) Nathalie Weibel 774
BBa_K4387990 VHH#3E + VHH#2B Bivalent Anti-Tumour Necrosis Factor Nanobody (VHH#3E + VHH#2B) Nathalie Weibel 792
BBa_K4387989 VHH#2B + VHH#12B Bivalent Anti-Tumour Necrosis Factor Nanobody (VHH#2B + VHH#12B) Nathalie Weibel 774
BBa_K4387988 VHH#3E + VHH#12B Bivalent Anti-Tumour Necrosis Factor Nanobody (VHH#3E + VHH#12B) Nathalie Weibel 792

Secretion system:

To allow the secretion of the produced nanobodies into the extracellular space, we decided to make use of the hemolysin A secretion system. Since TolC is already endogenously expressed in many E. coli strains, we only needed to encode the other two subunits (HlyB and HlyD) and mark our nanobody with the hemolysin A secretion tag.

Name Type Description Designers Length in bp Picture for composite parts
BBa_K4387999 HlyB HlyB of the hemolysin A one-step secretion system Nathalie Weibel 2124
BBa_K4387998 HlyD HlyD of the hemolysin A one-step secretion system Nathalie Weibel 1437
BBa_K4387997 HlyA-tag HlyA-tag obtained from the hemolysin A one-step secretion system Nathalie Weibel 654
BBa_K4387987 Secretion system Hemolysin A secretion system for E. coli Nathalie Weibel 3734
BBa_K4387986 Monovalent nanobody expression Monovalent nanobody expression with the HlyA secretion signal (VHH#2B) Nathalie Weibel 2421
BBa_K4387985 Monovalent nanobody expression Monovalent nanobody expression with the HlyA secretion signal (VHH#3E) Nathalie Weibel 2439
BBa_K4387984 Monovalent nanobody expression Monovalent nanobody expression with the HlyA secretion signal (VHH#12B) Nathalie Weibel 2421
BBa_K4387983 Bivalent nanobody expression Bivalent nanobody expression with the HlyA secretion signal (biv. VHH#2B) Nathalie Weibel 2826
BBa_K4387982 Bivalent nanobody expression Bivalent nanobody expression with the HlyA secretion signal (biv. VHH#3E) Nathalie Weibel 2862
BBa_K4387981 Bivalent nanobody expression Bivalent nanobody expression with the HlyA secretion signal (VHH#3E + VHH#2B) Nathalie Weibel 2844
BBa_K4387980 Bivalent nanobody expression Bivalent nanobody expression with the HlyA secretion signal (VHH#2B + VHH#12B) Nathalie Weibel 2826
BBa_K4387979 Bivalent nanobody expression Bivalent nanobody expression with the HlyA secretion signal (VHH#3E + VHH#12B) Nathalie Weibel 2844

Final construct:

Once all systems have been established and the best suited constructs identified, we Gibson-assembled a final plasmid, which would allow the inducible production of nanobodies upon nitric oxide sensing. The secretion system plasmid encoding for the secretion pore stayed the same. (See BBa_K4387987)

Name Type Description Designers Length in bp Picture for composite parts
BBa_K4387978 Nitric Oxide Sensing Genetic Circuit NO-induced monovalent nanobody expression Nathalie Weibel 3054